stoxline Quote Chart Rank Option Currency Glossary
  
Tivic Health Systems, Inc. (TIVC)
4.06  0 (0%)    07-14 16:00
Open: 4.024
High: 4.09
Volume: 32,051
  
Pre. Close: 4.06
Low: 3.8701
Market Cap: 4(M)
Technical analysis
2025-07-14 4:44:03 PM
Short term     
Mid term     
Targets 6-month :  5.18 1-year :  6.05
Resists First :  4.44 Second :  5.18
Pivot price 3.99
Supports First :  3.95 Second :  3.65
MAs MA(5) :  4.17 MA(20) :  3.94
MA(100) :  4.38 MA(250) :  4.91
MACD MACD :  0 Signal :  -0.1
%K %D K(14,3) :  56.5 D(3) :  71.4
RSI RSI(14): 50.7
52-week High :  16.08 Low :  0.23
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ TIVC ] has closed below upper band by 40.2%. Bollinger Bands are 81.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 38 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 4.09 - 4.11 4.11 - 4.13
Low: 3.82 - 3.84 3.84 - 3.86
Close: 4.03 - 4.06 4.06 - 4.09
Company Description

Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. Its primary product is ClearUP, is a medical device intended to relieve sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, including BestBuy.com and FSAStore.com. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.

Headline News

Thu, 10 Jul 2025
What do analysts say about TIVC's EPS outlook? - AInvest

Thu, 10 Jul 2025
Can TIVC's EPS recover in the next quarter? - AInvest

Tue, 08 Jul 2025
Tivic Shareholders Approve Key Proposals in Support of Strategic Transformation; Lisa Wolf Appointed Permanent CFO - Yahoo Finance

Wed, 25 Jun 2025
Tivic Health Systems Amends License Agreement with Statera - TipRanks

Tue, 24 Jun 2025
Tivic Health Announces 2025 Annual Meeting of Stockholders - Business Wire

Tue, 22 Apr 2025
Tivic Health Reports White House Briefing and FDA Meetings Secured Positive Interest in Potential Military and Defense Applications of Its Product Candidates - Business Wire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 0 (M)
Shares Float 1 (M)
Held by Insiders 765790 (%)
Held by Institutions 12.8 (%)
Shares Short 55 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -5.68e+006
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -2 %
Return on Assets (ttm) 151.4 %
Return on Equity (ttm) -100.7 %
Qtrly Rev. Growth 516000 %
Gross Profit (p.s.) -39.5
Sales Per Share -109.39
EBITDA (p.s.) -57500
Qtrly Earnings Growth -5.1 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -5 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.04
Price to Cash Flow 1.88
Stock Dividends
Dividend 0
Forward Dividend 37430
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android